for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Sierra Oncology Reports Qtrly Loss Per Share $0.19

May 10 (Reuters) - Sierra Oncology Inc:

* SIERRA ONCOLOGY REPORTS FIRST QUARTER RESULTS

* SIERRA ONCOLOGY INC QTRLY LOSS PER SHARE $0.19

* SIERRA ONCOLOGY INC - SRA737 MONOTHERAPY PHASE 1/2 TRIAL EXPANDED TO ENROLL CCNE1-DRIVEN OVARIAN CANCER COHORT

* SIERRA ONCOLOGY INC - SRA737 LOW-DOSE GEMCITABINE COMBINATION PHASE 1/2 TRIAL ADVANCED INTO COHORT EXPANSION PHASE

* SIERRA ONCOLOGY INC - CASH AND CASH EQUIVALENTS TOTALED $133.8 MILLION AS OF MARCH 31, 2018

* SIERRA ONCOLOGY INC - $133.8 MILLION CASH EXPECTED TO FUND PROGRAMS THROUGH APPROXIMATELY MID-2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up